Nurse Practitioner, Primary Care · Birmingham, AL
NPI
1144263898
Since 2006
Specialty
Nurse Practitioner, Primary Care
Code 363LP2300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
701 Princeton Ave SW Ste 4102
Birmingham, AL, 35211
Phone (205) 264-2050
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
394 services
Medicare patients, 2024
372
Average age 75
Drug cost, 2024
$1.7M
808 prescriptions
Company payments, 2025
$220
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amanda C Crawford was code 99214 (office e&m - established), 225 times for 221 patients. In total Amanda C Crawford billed 394 services in 8 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 225 | 221 | $48.77 | $11K |
| 99213 Office E&M - Established | Facility | 95 | 91 | $36.25 | $3,444 |
| 99215 Office E&M - Established | Facility | 44 | 44 | $71.65 | $3,153 |
| 99205 Office E&M - New | Facility | 12 | 12 | $77.22 | $927 |
By year: 2022 $24K for 427 services; 2023 $22K for 429 services; 2024 $19K for 394 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amanda C Crawford prescribed most often to Medicare patients was Alendronate Sodium, with 193 prescriptions and refills. In total Amanda C Crawford wrote 808 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alendronate Sodium Generic | 193 | 526 | 70 | $2,442 |
| Teriparatide Generic | 126 | 126 | 20 | $291K |
| Forteo Teriparatide | 107 | 107 | 14 | $431K |
| Risedronate Sodium Generic | 69 | 165 | 23 | $9,515 |
| Zoledronic Acid Zoledronic Acid/Mannitol-Water | 60 | 720 | 60 | $5,131 |
| Prolia Denosumab | 41 | 246 | 30 | $68K |
| Evenity (2 Syringes) Romosozumab-Aqqg | 37 | 37 | Under 11 | $86K |
| Tymlos Abaloparatide | 32 | 32 | Under 11 | $80K |
| Raloxifene Hcl Generic | 31 | 83 | Under 11 | $1,149 |
| Ibandronate Sodium Generic | 25 | 73 | 12 | $908 |
| Strensiq Asfotase Alfa | 16 | 16 | Under 11 | $716K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 13 | 40 | Under 11 | $735 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 11 | 34 | Under 11 | $626 |
Brand drugs: 269 claims; generic drugs: 507 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amanda C Crawford $220 ($220 in general payments such as food, travel and fees) from 2 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $167.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.